Medical news update
![](https://iraqhs.com/wp-content/uploads/2022/09/Picture2-752x440.png)
- Error in Figure 3
The Original Investigation titled “Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial,” published online […]
- Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement
This cohort study examines whether there is an association between osteosarcopenia and adverse outcomes, such as increased risk of mortality, in older adults following transcatheter aortic valve […]
- Becoming a Co-Survivor—Reflections From the ICU
This essay describes what the author learned from being in the intensive care unit with her father during multiple cardiac arrests and surgery.
- Osteosarcopenia and Mortality After Transcatheter Aortic Valve Replacement
Frailty, an age-related syndrome of physiologic decline and increased vulnerability to stressors, is associated with adverse health outcomes after surgical or transcatheter aortic valve replacement […]
- Physical Activity and Progression of Coronary Artery Calcification
This cohort study examines data for men and women 40 years and older to determine the association between high-volume leisure-time aerobic physical activity and the progression of coronary artery […]
- Rheumatic Heart Disease—A Neglected Tragedy in Young Patients
The United Nations Sustainable Development Goals for 2030 include a strong focus on health, wherein it is stated “…to extend life expectancy for all, we must achieve universal health coverage and […]
- Dual vs Single Cardioversion of Atrial Fibrillation in Patients With Obesity
This randomized clinical trial investigates which strategy is more effective in patients with atrial fibrillation and obesity: dual or single direct-current cardioversion.
- Error in Figure 4
The Original Investigation titled “Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial,” published online January 17, […]
![](https://iraqhs.com/wp-content/uploads/2022/09/bmj.jpg)
- Fostering diversity in clinical trials: need for evidence and implementation to improve representation
- Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies
- Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies
- Fostering diversity in clinical trials: need for evidence and implementation to improve representation
- Assessing the methodological quality and risk of bias of systematic reviews: primer for authors of overviews of systematic reviews
- Assessing the methodological quality and risk of bias of systematic reviews: primer for authors of overviews of systematic reviews
- Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPP
- Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPP
- Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study
- Regular use of fish oil supplements and course of cardiovascular diseases: prospective cohort study
![](https://iraqhs.com/wp-content/uploads/2022/09/journal-of-HT-screen-shot.png)
- Posts will be published when available. Sorry for inconvenience
![](https://iraqhs.com/wp-content/uploads/2022/09/AnyConv.com__esh.jpg)
- ESH Webinars 2024
PART 1: Updates on resistant hypertension from novel lifestyle interventions to new drugs and interventional therapies PART 2: Hypertension treatment challenges and options in comorbidities
- ESH Webinars 2024
Part I - February 20, 2024 | 17:00 (CET) Part II - March 19, 2024 | 17:00 (CET)
- ESH 2024
BERLIN MAY 31 - JUNE 3, 2024 www.eshannualmeetings.eu Abstracts are available in Journal of Hypertension
- NEW EUROPEAN GUIDELINES
The final version of the full guidelines is now available on the Journal of Hypertension website.
- ESH Hypertension Summer School
Date: September 15 – 20, 2024 Venue: Club Med Opio - Opio en Provence, France Application submission date extended to April 2, 2024
- Webinar series
HOT TOPICS IN HYPERTENSION MANAGEMENT - AUTUMN 2020 (Part 2) - NOW AVAILABLE.
- ESH Online Education
The European Society of Hypertension is pleased to announce the updated version of the ESH e-Learning Hypertension Self-Assessment Programme is now available.
- Test article 2
At solmen va esser necessi far uniform grammatica, pronunciation e plu sommun paroles.
![](https://iraqhs.com/wp-content/uploads/2022/09/jch-752x318.jpg)
- Factors affecting patient retention to hypertension treatment in a North Indian State: A mixed‐method study
The Journal of Clinical Hypertension, EarlyView.
- Evidence for routine brain‐to‐pelvis imaging and antiplatelet therapy in patients diagnosed with fibromuscular dysplasia
The Journal of Clinical Hypertension, EarlyView.
- Effect of salt substitute and antihypertensive medications among high cardiovascular risk patients: A sub‐study of Salt Substitute and Stroke Study (SSaSS)
The Journal of Clinical Hypertension, EarlyView.
- The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population‐based cross‐sectional study
The Journal of Clinical Hypertension, EarlyView.
- Myocardial work alterations with progressive left ventricular hypertrophy in patients with hypertension
The Journal of Clinical Hypertension, EarlyView.
- Association between renin‐angiotensin antagonism and COVID‐19–related mortality in patients with essential hypertension: A single center, retrospective cohort study
The Journal of Clinical Hypertension, EarlyView.
- The effects of a digital lifestyle intervention in patients with hypertension: Results of a pilot randomized controlled trial
The Journal of Clinical Hypertension, EarlyView.
- Anti‐hypertensive effect and potential mechanism of gastrodia‐uncaria granules based on network pharmacology and experimental validation
The Journal of Clinical Hypertension, EarlyView.
![](https://iraqhs.com/wp-content/uploads/2022/09/journal-of-human-HT-screen-shot-768x278.png)
- Exploring the link between blood pressure variability and atrial fibrillation: current insights and future directions
Journal of Human Hypertension, Published online: 18 July 2024; doi:10.1038/s41371-024-00936-zExploring the link between blood pressure variability and atrial fibrillation: current insights and future […]
- A Randomized trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared to Standard antihypertensive Therapy in hypErtension with low Renin (REMASTER): rationale and study design
Journal of Human Hypertension, Published online: 18 July 2024; doi:10.1038/s41371-024-00931-4A Randomized trial assessing Efficacy and safety of Mineralocorticoid receptor Antagonist therapy compared […]
- Hemodynamic responses to the cold pressor test in individuals with metabolic syndrome: a case-control study in a multiracial sample of adults
Journal of Human Hypertension, Published online: 17 July 2024; doi:10.1038/s41371-024-00938-xHemodynamic responses to the cold pressor test in individuals with metabolic syndrome: a case-control […]
- Correction: Exercise systolic blood pressures are unaffected by time of day in healthy young adults
Journal of Human Hypertension, Published online: 16 July 2024; doi:10.1038/s41371-024-00934-1Correction: Exercise systolic blood pressures are unaffected by time of day in healthy young adults
- Wearable cuffless blood pressure tracking: when will they be good enough?
Journal of Human Hypertension, Published online: 12 July 2024; doi:10.1038/s41371-024-00932-3Wearable cuffless blood pressure tracking: when will they be good enough?
- Cutoffs for white-coat and masked blood pressure effects: an ambulatory blood pressure monitoring study
Journal of Human Hypertension, Published online: 10 July 2024; doi:10.1038/s41371-024-00930-5Cutoffs for white-coat and masked blood pressure effects: an ambulatory blood pressure monitoring study
- First, a seat; then, an upgrade
Journal of Human Hypertension, Published online: 10 July 2024; doi:10.1038/s41371-024-00933-2First, a seat; then, an upgrade
- Correction: Transition between cardiometabolic conditions and body weight among women: which paths increase the risk of diabetes and cardiovascular diseases?
Journal of Human Hypertension, Published online: 04 July 2024; doi:10.1038/s41371-024-00928-zCorrection: Transition between cardiometabolic conditions and body weight among women: which paths […]
- Effect of Telecardiology After Hospital Discharge for Acute Coronary Syndromes
A clinical trial in the U.K. shows a significant reduction in hospital readmission.
- Intensive BP Reduction for Preventing Major Adverse Cardiovascular Events
A randomized trial showed benefits for patients with or without diabetes or prior stroke.
- Is High Lipoprotein(a) Associated with Risk for First MI in a Low-Risk Population?
Observational data show an association, regardless of the presence or number of other modifiable cardiovascular risk factors.
- Semaglutide for Obesity-Related Heart Failure with Preserved Ejection Fraction — Does Sex Matter?
Both men and women derived clinical benefit from semaglutide, although women lost more weight.
- Is Influenza a Risk Factor for Subsequent Acute Myocardial Infarction?
Another study supports an association between influenza and subsequent MI.
- Atrial Fibrillation and Cirrhosis: Which Anticoagulant?
Apixaban might present less bleeding risk than rivaroxaban or warfarin.
- What Are the Long-Term Effects of Dual vs. Single Antiplatelet Therapy After Coronary-Artery Bypass Grafting?
Long-term follow-up of a clinical trial from China suggests a lower risk for major adverse cardiovascular events with dual antiplatelet therapy.
- CCTA-Derived Inflammatory Markers and Cardiac Risk in Patients Without Obstructive CAD
Markers derived from computed tomography of the coronary arteries helped predict cardiovascular risk.